Increase Funding for Alzheimerās Research
Alzheimerās is a growing public health crisis. In 2017, the U.S. spent $259 billion in direct costs caring for individuals living with Alzheimerās or other dementias, $175 billion of which came in direct costs to Medicare and Medicaid.
And while Congress has more than tripled Alzheimerās and dementia research funding at the National Institutes of Health (NIH) in recent years, leading experts say a greater investment is still needed.
The Alzheimerās Association is asking Congress to approve an additional $425 million increase in the governmentās Fiscal Year 2019 budget.
This affects Kentucky directly. Today, there are 70,000 individuals in Kentucky living with Alzheimerās ā the only leading cause of death without a way to prevent, cure or even slow its progression.
Barring the development of medical breakthroughs, the number of Americans with the disease is set to triple over the next 35 years, and the cost of care will increase to $1.1 trillion in 2050. It is only through adequate funding that we will change this trajectory.
The Alzheimerās Association and its supporters are asking Central Kentuckians to join them in asking Representative Andy Barr to support an additional $425 million in Alzheimerās and dementia research funding at the NIH. Together we can end Alzheimerās.